Cell Sorting Market Size To Reach $569.1 Million By 2033

October 2025 | Report Format: Electronic (PDF)

Cell Sorting Market Growth & Trends

The global cell sorting market size is anticipated to reach USD 569.1 million by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.19% from 2025 to 2033. The market is expected to grow in the coming years owing to technological advancements in the field of cell sorting technologies and instruments. High speed sorters have the ability to differentiate between cell types effectively. This has improved research in genomics and proteomics as well as developing many emerging cell-based therapies. An advanced and emerging technology in this field is microfluidics.

A substantial expansion has been witnessed in the pharmaceutical and biotechnology industries, which is fostering more drug discovery research, thereby, fueling growth. Mergers, acquisitions, and collaborations are some of the main strategies undertaken by these companies in order to overcome competition. A booming Indian pharmaceutical sector is anticipated to result in a positive impact on the growth of the global market. According to the India Brand Equity Foundation (IBEF) 2019 statistics, currently, Indian pharmaceutical companies supply 80% of the antiretroviral drugs used for combating AIDS. In addition, growing number of research activities pertaining to new applications is another factor driving growth.

Request a free sample copy or view report summary: Cell Sorting Market Report

Cell Sorting Market Report Highlights

Reagents and consumables dominated the market with a revenue share of 64.29% in 2024. These products provide essential products for precise and efficient cell sorting.
Fluorescence-based droplet cell sorting (FACS) technology accounted for the largest revenue share of 42.14% in 2024 due to FACS's high precision, speed, and adaptability in separating particular cell populations using a variety of fluorescent markers.
Research applications held the largest market share in 2024. The significant funding directed by government and private organizations toward biomedical research is producing scientific gains.
Research institutions led the market with a revenue share of 38.90% in 2024. Top research institutions drive in the scientific domain concerning cancer biology, immunology, and stem cell biology.